少陽人 백반증 148예의 임상적 고찰
A Clinical Study of 148 Patients with Soyangin Vitiligo
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study is to evaluate the clinical aspects of patients with Soyangin vitiligo. Methods : This clinical investigation was made with 148 Soyangin Vitiligo patients who visited Haneulmaeum Oriental Medicine Clinic (Incheon) from July 1st 2007 to June 30th 2017. Results & Conclusions : 1. There were 73 males(49.3%) and 75 females(50.7%). 2. The Mean age at the first visit was 36.1 years(male: 36.4, female: 35.8). 3. The Mean age of onset was 27.9 years(male: 28.6, female: 27.4). 4. The mean duration of the disease was 8.0 years(male: 7.8, female: 8.3). 5. Of the 148 patients, 41(27.7%) had the symmetric lesions and 107(72.3%) had the asymmetric vitiligo lesions. Of the patients with asymmetric vitiligo lesions, 46(31.1%) had the localized lesions and 26(17.6%) had the segmental lesions and 35(24.3%) had the multiple lesions. 6. The most common site of initial involvement of the vitiligo was the face (39.2%). 7. The most common site of the vitiligo lesions was the face(49.3%). 8. Familial history was obtained in 12 patients(8.1%). 9. There was no known precipitating factor in most cases(89.4%). 10. Thyroid disease was the most common associated disease. 11. The progression of vitiligo was present in 92 patients(62.2%)
Abstract
Objectives : The purpose of this study is to evaluate the clinical aspects of patients with Soyangin vitiligo. Methods : This clinical investigation was made with 148 Soyangin Vitiligo patients who visited Haneulmaeum Oriental Medicine Clinic (Incheon) from July 1st 2007 to June 30th 2017. Results & Conclusions : 1. There were 73 males(49.3%) and 75 females(50.7%). 2. The Mean age at the first visit was 36.1 years(male: 36.4, female: 35.8). 3. The Mean age of onset was 27.9 years(male: 28.6, female: 27.4). 4. The mean duration of the disease was 8.0 years(male: 7.8, female: 8.3). 5. Of the 148 patients, 41(27.7%) had the symmetric lesions and 107(72.3%) had the asymmetric vitiligo lesions. Of the patients with asymmetric vitiligo lesions, 46(31.1%) had the localized lesions and 26(17.6%) had the segmental lesions and 35(24.3%) had the multiple lesions. 6. The most common site of initial involvement of the vitiligo was the face (39.2%). 7. The most common site of the vitiligo lesions was the face(49.3%). 8. Familial history was obtained in 12 patients(8.1%). 9. There was no known precipitating factor in most cases(89.4%). 10. Thyroid disease was the most common associated disease. 11. The progression of vitiligo was present in 92 patients(62.2%)
참고문헌 (26)
- Ortonne JP, "Hypomelanotic disorders: vitiligo and other hypomelanoses fo hair and skin", pp.120~310 (1983), Plenum
- Lerner AB, "Vitilgo", J Invest Dermatol, 32, pp.285~310 (1959)[DOI]
- Masher DB, "Dermatology in General Medicine", pp.582~590 (1979), McGraw-Hill Book
- Betterie C, "Incidence and significance of organ-specific autoimmune disorder in patients with vitiligo", Dermatologica, 171, pp.419~423 (1985)[DOI]
- Koga M, "Vitiligo: a new classification and therapy", Br J Dermatol, 97, pp.255~261 (1977)[DOI]
- Lerner AB, "On the etiology of vitiligo and gray hair", Am J Med, 51, pp.147~156 (1971)
- Karin US, "Free fadical reduction by Thioredoxin reductase at the surface of normal and vitiliginous haman keratinocytes", J Invest Dermatol, 87, pp.728~732 (1986)[DOI]
- Grimes PE, "T cell profiles in vitiligo", J Am Acad Dermatol, 14, pp.196~201 (1986)[DOI]
- Mosher DB, "Fitzpatrick's dermatology in general medicine", pp.945~1017 (1999), McGraw-Hill Book
- Cho S, "Characteristics of vitiligo in Korean children", Pediatr Dermatol, 17, pp.189~193 (2000)[DOI]
- Huggins RH, "Childhood vitiligo", Cutis, 79, pp.277~280 (2007)
- Koga M, "Clinical features and course of type A and type B vitiligo", Br J Dermatol, 118, pp.223~228 (1988)[DOI]
- 전은경, "백반증 병변의 대칭성의 임상적 의의", 대한피부과학회지, 46(1), pp.40~45 (2008), 대한피부과학회
- 전은경, "백반증 환자의 삶의 질 평가", 대한피부과학회지, 46(7), pp.874~880 (2008), 대한피부과학회
- Hong SY, "Principles of Sasang Medicine", pp.134~ (1994), Haenglim
- Ji SY, "The study on the oriental and western Medical literatures of vitiligo", J of Jaehan Oriental Medical academy, 4(1), pp.262~285 (1999)
- Park SR, "Clinical study of 217 cases of vitiligo", Korean J Dermatol, 19, pp.171~182 (1981)
- Park KC, "Clinical study of 326 cases of vitiligo", Korean J Dermatol, 26, pp.200~205 (1988)
- Yu HJ, "Clinical study of vitiligo", Korean J Dermatol, 36, pp.1037~1042 (1998)
- Levai M, "A study of certain contributory factors in the development of vitiligo in South Indian patients", Arch Dermatol, 78, pp.364~371 (1958)[DOI]
- Kim YC, "The genetics of vitiligo in Korean patients", Korean J Dermatol, 34, pp.968~972 (1996)
- Halder RM, "Fitzpatrick's dermatology in general medicine", pp.616~622 (2008), McGraw-Hill
- Halder RM, "Childhood vitiligo", J Am Acad Dermatol, 16, pp.948~954 (1987)[DOI]
- Kovacs SO, "Vitiligo", J Am Acad Dermatol, 38, pp.647~666 (1998)[DOI]
- Cunliffe WJ, "Vitiligo, thyroid disease and autoimmunity", Br J Dermatol, 80, pp.135~139 (1968)[DOI]
- Kim TH, "The recent therapeutics of vitiligo", Korean J Dermatol, 59, pp.113~ (2007)